動物バイオテクノロジーの市場規模、シェア、動向分析レポート：製品別、用途別、動物タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

動物バイオテクノロジー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の動物バイオテクノロジーの市場規模は、2030年までに490億3,000万米ドルに達すると予測されています。

市場は2025年から2030年にかけてCAGR9.89％で成長すると予測されています。主な成長要因は、政府の取り組みやキャンペーン、動物衛生バイオテクノロジーの革新や最近の進歩、動物遺伝子検査に関する教育への取り組みの拡大、人畜共通感染症の発生率の上昇などです。例えば、2021年1月、カナダとオンタリオ州政府は、カナダ農業パートナーシップを通じて最大400万米ドルを提供し、農家が必要なときに必要な場所で獣医サービスを受けられるように改善します。

世界中でCOVID-19の流行が増加しているため、多くの国が、獣医療には緊急または緊急の処置のみが確実に必要であると定めています。ワクチン接種などの日常診療の遅れは、ある種の深刻な健康と福祉の問題につながっています。さらに、COVID-19規制解除後の過剰な業務が、こうしたサービスの提供にさらなる遅れを生み出しています。獣医師の診察と診断検査は、2020年3月、4月、5月には大幅に減少しましたが、2020年第3四半期からは高い伸び率で改善し始めました。

主要企業は、制限やサプライチェーンの混乱にもかかわらず、パンデミック中の成長を観察しました。Neogen Corporationの2020年度の連結売上高は4億1,820万米ドルで、2019年度と比較して1.0％増加しました。さらに2022年6月には、インド初の動物用COVID-19ワクチンAnocovaxが発売されました。Anocovacの他に、インドの農業大臣は、イヌのSARS-CoV-2に対する抗体検出のための「CAN-CoV-2 ELISAキット」（特異的ヌクレオカプシドタンパク質ベースの間接ELISAキット）を発表しました。このような開発は市場全体の成長を促進します。

業界の成長に寄与しているその他の属性には、農業における動物の使用に対する需要の改善、動物の健康と福祉、食肉、動物由来製品に対する意識の高まり、ヒト用医薬品の開発における動物の役割の拡大、ペットの飼育率の増加、市場プレイヤーの研究開発投資の増加などがあります。2021年8月、INDICAL BIOSCIENCE GmbHはオランダの研究開発特化型企業Check-Pointsを買収しました。

この業界は競争が激しく、主要企業は製品イノベーション、新製品開発、流通契約、市場浸透率向上のための拡大戦略に注力しています。2021年10月、Embark Veterinary, Inc.は純血種の犬のDNA検査をリリースしました。このキットは純血種の飼い主に独占的で実用的な健康情報を提供し、ピンポイントの診断、治療計画、モニタリングを支援するもので、獣医師と簡単に共有できます。

動物バイオテクノロジー市場レポートハイライト

• ワクチン製品タイプは、2024年に最大の収益を生み出すセグメントです。ワクチン接種は動物の疾病負担を軽減する効果的な方法であり、予防ヘルスケアと疾病管理において重要な役割を果たしています。2021年12月、Indian Immunologicals Ltd.がヤギ痘ワクチンを発表しました。
• コンパニオンアニマルの採用が増加しているため、動物の予防医療用途セグメントが2024年に最大の収益シェアを占めました。HABRIとZoetisによる国際調査では、人間と動物の絆と一貫した獣医療との間に直接的な関係があることを示しています。したがって、このような人間と動物の絆は、より良い予防医療へと前進します。
• コンパニオンアニマルタイプのセグメントは、効率的な動物ケアと、関連する健康上の利点によるペットと人間の絆に対する需要の増加により、予測期間中に大きく成長すると思われます。
• コンパニオンアニマルタイプのセグメントでは、犬が2024年に最大の収益シェアを占めました。犬は、人間が罹患するのと同じがんの多くに罹患しやすいです。米国国立がん研究所によると、犬では毎年600万件近くのがんが新たに診断されています。
• その他の最終用途分野では、獣医学研究機関や大学が、高度な診断ツールや治療的に高度なワクチンや医薬品を開発するための研究開発資金の増加により、予測期間中に有利な速度で成長すると予想されています。
• 北米が2024年に最大の売上シェアを占めたのは、動物に対する認識レベルが高く、老舗の市場プレーヤーが存在し、ヘルスケアインフラが整備されているためです。2021年10月、Zoetis Inc.はアイルランドのタラモアに製造開発施設を拡張しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 動物バイオテクノロジー市場の変動動向と範囲

• 市場系統の見通し
  • 親市場
  • 補助市場
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 動物バイオテクノロジー市場分析ツール
  • 業界分析 - ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み
  • 動物の推定個体数：主要国別・主要種別（2018年～2023年）
  • 製品価格分析
  • COVID-19の影響分析

第4章 動物バイオテクノロジー市場：製品の推定・動向分析

• セグメントダッシュボード
• 動物バイオテクノロジー市場の製品変動分析
• 動物バイオテクノロジー市場規模と動向分析、製品別、2018年～2030年
  • 診断
  • 生物学的製剤
  • 薬物
  • 生殖・遺伝
  • 栄養

第5章 動物バイオテクノロジー市場：用途の推定・動向分析

• セグメントダッシュボード
• 動物バイオテクノロジー市場の用途変動分析
• 動物バイオテクノロジー市場規模と動向分析、用途別、2018年～2030年
  • 動物の病気の診断
  • 動物の病気の治療
  • 動物の予防ケア
  • 製品研究開発
  • その他の用途

第6章 動物バイオテクノロジー市場：動物の推定・動向分析

• セグメントダッシュボード
• 動物バイオテクノロジー市場の動物変動分析
• 動物バイオテクノロジー市場規模と動向分析、動物別、2018年～2030年
  • 家畜
  • コンパニオン

第7章 動物バイオテクノロジー市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 動物バイオテクノロジー市場の最終用途変動分析
• 動物バイオテクノロジー市場の規模と動向分析、最終用途別、2018年～2030年
  • 研究所
  • ポイントオブケア検査 / 院内検査
  • 動物病院・クリニック
  • その他の用途

第8章 動物バイオテクノロジー市場：国別の推定・動向分析、製品、用途、動物、最終用途別

• 地域ダッシュボード
• 動物バイオテクノロジー市場シェア、地域別、2023年・2030年、百万米ドル
• 地域展望
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• 参入企業の概要
• 財務実績
• 製品ベンチマーク
• 市況分析、2023年（ヒートマップ分析）
• 戦略マッピング
  • 合併と買収
  • 発売
  • パートナーシップ・コラボレーション
  • 拡大
  • その他
• 企業プロファイル
  • Zoetis
  • Boehringer Ingelheim
  • Merck &Co. Inc.
  • Virbac
  • Elanco
  • Idexx Laboratories
  • Dechra Pharmaceuticals
  • Heska Corporation
  • Indian Immunologicals Ltd.
  • Hester Biosciences Pvt. Ltd.
  • Biogenesis Bago
• その他市場企業一覧

第10章 重要なポイント

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 4 Global Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 5 Global Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 6 Global Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 7 Global Animal Biotechnology Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Animal Biotechnology Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 10 North America Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 11 North America Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 12 North America Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 14 U.S. Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 15 U.S. Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 16 U.S. Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 17 Canada Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 18 Canada Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 19 Canada Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 20 Canada Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 21 Mexico Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 22 Mexico Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 23 Mexico Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 24 Mexico Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 25 Europe Animal Biotechnology Market, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 27 Europe Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 28 Europe Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 29 Europe Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 30 Germany Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 31 Germany Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 32 Germany Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 33 Germany Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 34 UK Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 35 UK Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 36 UK Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 37 UK Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 38 France Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 39 France Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 40 France Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 41 France Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 42 Italy Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 43 Italy Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 44 Italy Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 45 Italy Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 46 Spain Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 47 Spain Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 48 Spain Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 49 Spain Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 50 Denmark Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 51 Denmark Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 52 Denmark Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 53 Denmark Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 54 Sweden Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 55 Sweden Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 56 Sweden Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 57 Sweden Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 58 Norway Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 59 Norway Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 60 Norway Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 61 Norway Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Animal Biotechnology Market, by Country, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 67 China Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 68 China Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 69 China Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 70 China Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 71 Japan Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 72 Japan Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 73 Japan Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 74 Japan Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 75 India Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 76 India Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 77 India Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 78 India Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 79 South Korea Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 80 South Korea Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 81 South Korea Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 82 South Korea Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 83 Australia Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 84 Australia Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 85 Australia Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 86 Australia Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 87 ThailandAnimal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 88 ThailandAnimal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 89 ThailandAnimal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 90 ThailandAnimal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 91 Latin America Animal Biotechnology Market, by Country, 2018 - 2030 (USD Million)
• Table 92 Latin America Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 93 Latin America Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 94 Latin America Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 95 Latin America Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 96 Brazil Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 97 Brazil Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 98 Brazil Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 99 Brazil Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 100 Brazil Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 101 Argentina Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 102 Argentina Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 103 Argentina Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa Animal Biotechnology Market, by Country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 109 South Africa Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 110 South Africa Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 111 South Africa Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 112 South Africa Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 117 UAE Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 118 UAE Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 119 UAE Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 120 UAE Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)
• Table 121 Kuwait Animal Biotechnology Market, By Product, 2018 - 2030 (USD Million)
• Table 122 Kuwait Animal Biotechnology Market, By Application, 2018 - 2030 (USD Million)
• Table 123 Kuwait Animal Biotechnology Market, By Animal, 2018 - 2030 (USD Million)
• Table 124 Kuwait Animal Biotechnology Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Animal Biotechnology Market, Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Global Animal Biotechnology Market, for Product,2018 - 2030 (USD Million)
• Fig. 15 Global Animal Biotechnology Market, for Diagnostics, 2018 - 2030 (USD Million)
• Fig. 16 Global Animal Biotechnology Market, for Biologics, 2018 - 2030 (USD Million)
• Fig. 17 Global Animal Biotechnology Market, for Drugs,2018 - 2030 (USD Million)
• Fig. 18 Global Animal Biotechnology Market, for Reproductive And Genetic, 2018 - 2030 (USD Million)
• Fig. 19 Global Animal Biotechnology Market, for Nutrition, 2018 - 2030 (USD Million)
• Fig. 20 Global Animal Biotechnology Market, for Application,2018 - 2030 (USD Million)
• Fig. 21 Global Animal Biotechnology Market, for Diagnosis of Animal Diseases, 2018 - 2030 (USD Million)
• Fig. 22 Global Animal Biotechnology Market, for Treatment of Animal Diseases,2018 - 2030 (USD Million)
• Fig. 23 Global Animal Biotechnology Market, for Preventive Care of Animals,2018 - 2030 (USD Million)
• Fig. 24 Global Animal Biotechnology Market, for Product Research & Development, 2018 - 2030 (USD Million)
• Fig. 25 Global Animal Biotechnology Market, for Other Applications,2018 - 2030 (USD Million)
• Fig. 26 Global Animal Biotechnology Market, for Animal,2018 - 2030 (USD Million)
• Fig. 27 Global Animal Biotechnology Market, for Livestock,2018 - 2030 (USD Million)
• Fig. 28 Global Animal Biotechnology Market, for Fish,2018 - 2030 (USD Million)
• Fig. 29 Global Animal Biotechnology Market, for Companion, 2018 - 2030 (USD Million)
• Fig. 30 Global Animal Biotechnology Market, for End Use,2018 - 2030 (USD Million)
• Fig. 31 Global Animal Biotechnology Market, for Laboratories,2018 - 2030 (USD Million)
• Fig. 32 Global Animal Biotechnology Market, for Point-of-care testing/In-house testing,2018 - 2030 (USD Million)
• Fig. 33 Global Animal Biotechnology Market, for Veterinary Hospitals & Clinics, 2018 - 2030 (USD Million)
• Fig. 34 Global Animal Biotechnology Market, for Other End Use,2018 - 2030 (USD Million)
• Fig. 35 Regional Outlook, 2024 & 2030
• Fig. 36 North America Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 37 U.S. Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 38 Canada Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 39 Mexico Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 40 Europe Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 41 Germany Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 42 UK Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 43 France Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 44 Italy Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 45 Spain Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 46 Denmark Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 47 Sweden Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 48 Norway Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 49 Asia Pacific Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 50 Japan Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 51 China Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 52 India Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 53 Australia Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 54 South Korea Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 55 Thailand Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 56 Latin America Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 57 Brazil Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 58 Argentina Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 59 Middle East and Africa Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 60 South Africa Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 61 Saudi Arabia Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 62 UAE Animal Biotechnology Market, 2018 - 2030 (USD Million)
• Fig. 63 Kuwait Animal Biotechnology Market, 2018 - 2030 (USD Million)

Animal Biotechnology Market Growth & Trends:

The global animal biotechnology market size is anticipated to reach USD 49.03 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.89% from 2025 to 2030. The major growth factors are government initiatives and campaigns, innovations and recent advances in animal health biotechnology, growing initiatives to educate regarding animal genetic testing and rising incidence of zoonotic diseases. For instance, in January 2021, the governments of Canada and Ontario are providing up to $4 million through the Canadian Agricultural Partnership to offer farmers improved access to veterinary services when and where they require it.

Due to a rise in the prevalence of COVID-19 across the world, many nations stipulated that only emergency or urgent procedures are certainly necessary for veterinary healthcare. Delays in routine care such as vaccination have led to certain serious health and welfare problems. Moreover, an excess of work after the lifting of COVID-19 restrictions has created further delays in the delivery of such services. Veterinary visits and diagnostic testing were significantly reduced in March, April, and May 2020 but started improving from the third quarter of 2020 with a high growth rate.

Major players observed growth during the pandemic despite the restriction and supply chain disruption. Consolidated revenues of Neogen Corporation were USD 418.2 million in fiscal 2020, an upsurge of 1.0% compared to 2019. Moreover, in June 2022, India's first COVID-19 vaccine Anocovax for animals launched. Besides Anocovac, the Agriculture Minister of India unveiled the 'CAN-CoV-2 ELISA kit' -- specific nucleocapsid protein-based indirect ELISA kit -- for antibody detection against SARS-CoV-2 in canines. Thus, such developments promote overall market growth.

Other attributes contributing to the industry growth comprise improved demand for the usage of animals in agriculture, growing awareness of animal health and welfare, meat, and animal-based products, expanding role of animals in the development of pharmaceuticals for humans, growing pet adoption, and increasing R&D investments from market players. In August 2021, INDICAL BIOSCIENCE GmbH acquired the Check-Points, Dutch R&D-focused corporation.

The industry is highly competitive as major players are focusing on product innovation, new product developments, distribution agreements, and expansion strategies to improve their market penetration. In October 2021, Embark Veterinary, Inc. released its DNA test for purebred dogs. The kit offers purebred owners exclusive, actionable health information to assist in pinpoint diagnostic, treatment plans, and monitoring that can easily be shared with a veterinarian.

Animal Biotechnology Market Report Highlights:

• The vaccine product type segment was the largest revenue-generating segment in 2024. Vaccination is an effective way to lower the disease burden in animals, and it plays an important role in preventive healthcare and disease control. In December 2021, Indian Immunologicals Ltd. introduced Goat Pox Vaccine
• The preventive care of animals application segment accounted for the largest revenue share in 2024 due to the growing adoption of companion animals. An international survey by HABRI and Zoetis indicates a direct relationship between the human-animal bond and consistent veterinary care. Thus, such a human-animal bond advances to better preventive care
• The companion animal type segment is likely to grow lucratively during the forecast period owing to an increase in demand for efficient animal care and the pet-human bond owing to the associated health benefits
• In the companion animal type segment, dogs held the largest revenue share in 2024. Dogs are prone to many of the same cancers that affect humans. As per the National Cancer Institute, nearly 6 million new cancer diagnoses are made in dogs every year
• In the other, end-use segment, veterinary research institutes, and universities are expected to grow at a lucrative rate over the forecast period owing to growing R&D funding to develop advanced diagnostic tools and therapeutically advanced vaccines and medicines
• North America accounted for the largest revenue share in 2024 owing to high animal awareness levels, the presence of well-established market players, and improved healthcare infrastructure. In October 2021, Zoetis Inc. expanded its manufacturing and development facility in Tullamore, Ireland

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Animal Biotechnology Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising R&D initiatives
    • 3.2.1.2. Rising Prevalence of Different Diseases in Animals
    • 3.2.1.3. Increasing Regulatory Control
    • 3.2.1.4. Support Initiatives by Industry Participants
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Technology limitations in under-developed regions
    • 3.2.2.2. Limited Resources & Funding
    • 3.2.2.3. Ethical Concerns
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Animal Biotechnology Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental Landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2023
  • 3.3.5. Product Pricing Analysis
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Animal Biotechnology Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Animal Biotechnology Market Product Movement Analysis
• 4.3. Animal Biotechnology Market Size & Trend Analysis, By Product, 2018 - 2030 (USD Million)
  • 4.3.1. Diagnostics
    • 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.2. Biologics
    • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.3. Drugs
    • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.4. Reproductive And Genetic
    • 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.5. Nutrition
    • 4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Animal Biotechnology Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Animal Biotechnology Market Application Movement Analysis
• 5.3. Animal Biotechnology Market Size & Trend Analysis, By Application, 2018 - 2030 (USD Million)
  • 5.3.1. Diagnosis of Animal Diseases
    • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.2. Treatment of Animal Diseases
    • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Preventive Care of Animals
    • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Product Research & Development
    • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.5. Other Applications
    • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Animal Biotechnology Market: Animal Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Animal Biotechnology Market Animal Movement Analysis
• 6.3. Animal Biotechnology Market Size & Trend Analysis, By Animal, 2018 - 2030 (USD Million)
  • 6.3.1. Livestock
    • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.1.2. Poultry
      • 6.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.1.3. Swine
      • 6.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.1.4. Cattle
      • 6.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.1.5. Sheep & Goats
      • 6.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.1.6. Fish
      • 6.3.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Companion
    • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2.2. Dogs
      • 6.3.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2.3. Cats
      • 6.3.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2.4. Horses
      • 6.3.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2.5. Other Companion
      • 6.3.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Animal Biotechnology Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Animal Biotechnology Market End Use Movement Analysis
• 7.3. Animal Biotechnology Market Size & Trend Analysis, By End Use, 2018 - 2030 (USD Million)
  • 7.3.1. Laboratories
    • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Point-of-care testing/In-house testing
    • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Veterinary Hospitals & Clinics
    • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.4. Other end use

Chapter 8. Animal Biotechnology Market: Country Estimates & Trend Analysis, by product, application, animal, & end use

• 8.1. Regional Dashboard
• 8.2. Animal Biotechnology Market Share, By Region, 2023 & 2030 USD Million
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competition Insights
    • 8.4.2.3. U.S. Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competition Insights
    • 8.4.3.3. Canada Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competition Insights
    • 8.4.4.3. Mexico Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competition Insights
    • 8.5.2.3. UK Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competition Insights
    • 8.5.3.3. Germany Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competition Insights
    • 8.5.4.3. France Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competition Insights
    • 8.5.5.3. Italy Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competition Insights
    • 8.5.6.3. Spain Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competition Insights
    • 8.5.7.3. Denmark Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competition Insights
    • 8.5.8.3. Sweden Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competition Insights
    • 8.5.9.3. Norway Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competition Insights
    • 8.6.2.3. Japan Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competition Insights
    • 8.6.3.3. China Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competition Insights
    • 8.6.4.3. India Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competition Insights
    • 8.6.5.3. Australia Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competition Insights
    • 8.6.6.3. South Korea Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competition Insights
    • 8.6.7.3. Thailand Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competition Insights
    • 8.7.2.3. Brazil Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competition Insights
    • 8.7.3.3. Argentina Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competition Insights
    • 8.8.2.3. South Africa Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competition Insights
    • 8.8.3.3. Saudi Arabia Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competition Insights
    • 8.8.4.3. UAE Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competition Insights
    • 8.8.5.3. Kuwait Animal Biotechnology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Participants Overview
• 9.3. Financial Performance
• 9.4. Product Benchmarking
• 9.5. Market Position Analysis, 2023 (Heat Map Analysis)
• 9.6. Strategy Mapping
  • 9.6.1. Mergers And Acquisitions
  • 9.6.2. Launch
  • 9.6.3. Partnerships & Collaborations
  • 9.6.4. Expansion
  • 9.6.5. Others
• 9.7. Company Profiles
  • 9.7.1. Zoetis
    • 9.7.1.1. Participant's overview
    • 9.7.1.2. Financial performance
    • 9.7.1.3. Product Benchmarking
    • 9.7.1.4. Strategic initiatives
  • 9.7.2. Boehringer Ingelheim
    • 9.7.2.1. Participant's overview
    • 9.7.2.2. Financial performance
    • 9.7.2.3. Product Benchmarking
    • 9.7.2.4. Strategic initiatives
  • 9.7.3. Merck & Co. Inc.
    • 9.7.3.1. Participant's overview
    • 9.7.3.2. Financial performance
    • 9.7.3.3. Product Benchmarking
    • 9.7.3.4. Strategic initiatives
  • 9.7.4. Virbac
    • 9.7.4.1. Participant's overview
    • 9.7.4.2. Financial performance
    • 9.7.4.3. Product Benchmarking
    • 9.7.4.4. Strategic initiatives
  • 9.7.5. Elanco
    • 9.7.5.1. Participant's overview
    • 9.7.5.2. Financial performance
    • 9.7.5.3. Product Benchmarking
    • 9.7.5.4. Strategic initiatives
  • 9.7.6. Idexx Laboratories
    • 9.7.6.1. Participant's overview
    • 9.7.6.2. Financial performance
    • 9.7.6.3. Product Benchmarking
    • 9.7.6.4. Strategic initiatives
  • 9.7.7. Dechra Pharmaceuticals
    • 9.7.7.1. Participant's overview
    • 9.7.7.2. Financial performance
    • 9.7.7.3. Product Benchmarking
    • 9.7.7.4. Strategic initiatives
  • 9.7.8. Heska Corporation
    • 9.7.8.1. Participant's overview
    • 9.7.8.2. Financial performance
    • 9.7.8.3. Product Benchmarking
    • 9.7.8.4. Strategic initiatives
  • 9.7.9. Indian Immunologicals Ltd.
    • 9.7.9.1. Participant's overview
    • 9.7.9.2. Financial performance
    • 9.7.9.3. Product Benchmarking
    • 9.7.9.4. Strategic initiatives
  • 9.7.10. Hester Biosciences Pvt. Ltd.
    • 9.7.10.1. Participant's overview
    • 9.7.10.2. Financial performance
    • 9.7.10.3. Product Benchmarking
    • 9.7.10.4. Strategic initiatives
  • 9.7.11. Biogenesis Bago
    • 9.7.11.1. Participant's overview
    • 9.7.11.2. Financial performance
    • 9.7.11.3. Product Benchmarking
    • 9.7.11.4. Strategic initiatives
• 9.8. List of Other Market Players

Chapter 10. Key Takeaways